
Results
2
Companies which are more than 50% undervalued based on analyst price target.
2 companies
Photocure
Market Cap: NOK 1.4b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHO
NOK 52.70
7D
4.2%
1Y
-14.6%
Lytix Biopharma
Market Cap: NOK 622.9m
A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.
LYTIX
NOK 8.08
7D
-4.9%
1Y
-12.4%